EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Caplacizumab in children: confirm diagnosis, tailor dose

Tang-Her Jaing, Yi-Lun Wang

Blood Vessels, Thrombosis & Hemostasis · 2026-11 · 3 (4) · 100232

DOI: 10.1016/j.bvth.2026.100232 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Blood Vessels, Thrombosis & Hemostasis, 2026-11. Verfasst von Tang-Her Jaing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Die Arbeit nennt 7 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Hematology and Oncology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
  • School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Zitieren

APA

Jaing, T. H., & Wang, Y. L. (2026). Caplacizumab in children: confirm diagnosis, tailor dose. Blood Vessels, Thrombosis & Hemostasis, 3(4), 100232. https://doi.org/10.1016/j.bvth.2026.100232

Vancouver

Jaing TH, Wang YL. Caplacizumab in children: confirm diagnosis, tailor dose. Blood Vessels, Thrombosis & Hemostasis. 2026;3(4):100232. doi:10.1016/j.bvth.2026.100232

BibTeX
@article{Jaing2026,
  author = {Jaing, Tang-Her and Wang, Yi-Lun},
  title = {Caplacizumab in children: confirm diagnosis, tailor dose},
  journal = {Blood Vessels, Thrombosis & Hemostasis},
  year = {2026},
  volume = {3},
  number = {4},
  pages = {100232},
  doi = {10.1016/j.bvth.2026.100232}
}
Kostenlos starten →